Literature DB >> 7862624

Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.

E G Van Meir1, K Roemer, A C Diserens, T Kikuchi, S A Rempel, M Haas, H J Huang, T Friedmann, N de Tribolet, W K Cavenee.   

Abstract

Mutation of the p53 tumor suppressor gene is one of the earliest identified genetic lesions during malignant progression of human astrocytomas. To assess the functional significance of these mutations, wild-type (WT) p53 genes were introduced into glioblastoma cell lines having mutant, WT, or null endogenous p53 alleles. Populations of cells with mutant or null endogenous p53 alleles and exogenous WT p53 were spontaneously selected in culture for cells expressing only mutant p53 or no p53, which then displayed a growth and tumorigenic phenotype identical to the parental cells. To determine the phenotypic consequences of WT p53 expression before the occurrence of mutations, we developed a single cell assay to monitor WT p53-dependent transcription activity. Transfer and expression of exogenous WT p53 genes to cells with endogenous mutant or deleted, but not WT, p53 alleles caused growth arrest and morphological changes, including increased cell size and acquisition of multiple nuclei. This supports the hypothesis that genetic lesions of the p53 gene play an important role in the genesis of astrocytomas. Furthermore, the high sensitivity of the episomal single cell reporter strategy developed here has potential clinical applications in the rapid screening of patients for germ-line mutations of the p53 gene or any other gene with known targets for transcriptional transactivation.

Entities:  

Mesh:

Year:  1995        PMID: 7862624      PMCID: PMC42626          DOI: 10.1073/pnas.92.4.1008

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro.

Authors:  G H Stein
Journal:  J Cell Physiol       Date:  1979-04       Impact factor: 6.384

2.  Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration.

Authors:  J L Sherley
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

3.  Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.

Authors:  J Cheng; J K Yee; J Yeargin; T Friedmann; M Haas
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

4.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  Unbalanced cell growth and increased protein synthesis induced by chemotherapeutic agents.

Authors:  D W Ross
Journal:  Blood Cells       Date:  1983

6.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

7.  Analysis of the p53 gene and its expression in human glioblastoma cells.

Authors:  E G Van Meir; T Kikuchi; M Tada; H Li; A C Diserens; B E Wojcik; H J Huang; T Friedmann; N de Tribolet; W K Cavenee
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

8.  Cytologic observations on the effects of metallocene dichlorides on human fibroblasts cultivated in vitro.

Authors:  P Köpf-Maier; G Hermann
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

9.  Clonal expansion of p53 mutant cells is associated with brain tumour progression.

Authors:  D Sidransky; T Mikkelsen; K Schwechheimer; M L Rosenblum; W Cavanee; B Vogelstein
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

10.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

View more
  12 in total

1.  Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.

Authors:  J Ikeda; M Tada; N Ishii; H Saya; K Tsuchiya; K Okaichi; K Mishima; Y Sawamura; G Fulci; T J Liu; E G Van Meir
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

2.  Cellular aging is a critical determinant of primary cell resistance to v-src transformation.

Authors:  N Tavoloni; H Inoue
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.

Authors:  C Fels; C Schäfer; B Hüppe; H Bahn; V Heidecke; C M Kramm; C Lautenschläger; N G Rainov
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

Review 4.  The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Authors:  S S Andreansky; B He; G Y Gillespie; L Soroceanu; J Markert; J Chou; B Roizman; R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Delivery of cell cycle genes to block astrocytoma growth.

Authors:  J Fueyo; C Gomez-Manzano; T J Liu; W K Yung
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.

Authors:  J A Kraus; M Wenghoefer; N Glesmann; S Mohr; M Beck; M C Schmidt; R Schröder; U Berweiler; W Roggendorf; S Diete; K Dietzmann; K Heuser; B Müller; R Fimmers; A von Deimling; U Schlegel
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 7.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

Review 8.  Genetic and hypoxic regulation of angiogenesis in gliomas.

Authors:  Balveen Kaur; Chalet Tan; Daniel J Brat; Dawn E Post; Erwin G Van Meir
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

9.  Induction of differentiation by wild-type p53 gene in a human glioma cell line.

Authors:  T Kokunai; A Kawamura; N Tamaki
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

10.  Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.

Authors:  M Trepel; P Groscurth; U Malipiero; E Gulbins; J Dichgans; M Weller
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.